Article
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
Journal of Alzheimer's disease : JAD - 1 Jan 2014
Bedse Gaurav, Romano Adele, Cianci Silvia, Lavecchia Angelo M, Lorenzo Pace, Elphick Maurice R, Laferla Frank M, Vendemiale Gianluigi, Grillo Caterina, Altieri Fabio, Cassano Tommaso, Gaetani Silvana
Abstract excerpt
The endocannabinoid system has gained much attention as a new potential pharmacotherapeutic target in various neurodegenerative diseases, including Alzheimer's disease (AD). However, the association between CB1 alterations and the development of AD neuropathology is unclear and often contradictory. In this study, brain CB1 mRNA and CB1 protein levels were analyzed in 3 × Tg-AD mice and compared to wild-type...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
